[1]
P. Manckoundia, J. Vovelle, S. Cancemi, R. Mahmoudi, and T. Renoncourt, “Movement disorders that occurred as late manifestations of Alzheimer’s disease controlled by a low dose of carbamazepine”, EJCRIM, vol. 12, no. 1, Dec. 2024, doi: 10.12890/2024_004943.